REFERENCES
- World Health Organization (WHO). Pandemic (H1N1) 2009 update. 2009. Available at: http://wwwwhoint/csr/don/ 2009_09_11/ en/ indexhtml. Accessed September 14, 2009.
- Garten RJ, Davis CT, Russell CA, . Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197–201.
- Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawwood DF, Jain S, Finelli L, Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615.
- Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection California, April–May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536–541.
- Centers for Disease Control and Prevention (CDC). H1N1 vaccination recommendations. 2009. CMAJ. 2010;182:257–264.
- Launes C, Rives S, Catala A, . Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukemia. Br J Haematol. 2010;149:874–878.
- Caselli D, Carraro F, Castagnola E, . Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer. 2010;55:226–228.
- Moricke A, Reiter A, Zimmermann M, Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment result of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477–4489.
- Creutzig U, Zimmermann M, Lehrnbecher T, Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol. 2006;24:4499–4506.
- Kharfan-Dabaja MA, Velez A, Richards K, Inflluenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol. 2010;91:124–127.
- The Health Ministry of Republic of Turkey. Pandemic influenza A (H1N1) bulletin. Available at: http://www.saglik.gov.tr. Accessed January 5, 2010.
- O’Riordan S, Barton M, Yau Y, Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ. 2010;182:39–44.
- Morgan OW, Bromley A, Fowlken A, Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PloS ONE. 2010;5:e9694.
- CDC. Updated ınterim recommendations for the use of antiviral medications in the treatment and prevention of ınfluenza for the 2009–2010 season. Available at: http://www.cdc.gov/h1n1flu/recommendations.htm. Last accessed October 22, 2009.
- European Centre for Disease Prevention and Control (ECDC). On public health use of ınfluenza antivirals during ınfluenza pandemics (with particular reference to the pandemic (H1N1) 2009). Available at: http://www.ecdc.europa.eu/en/healthtopics/Documents/ 0908 Influenza A H1N1 On Public Health Use of Influenza Antivirals during Influenza Pandemics.pdf. Last accessed October 22, 2009.
- WHO. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 ınfluenza and other ınfluenza viruses. Available at: http://www.who.int/entity/csr/resources/ publications/swineflu/h1n1_guidelines pharmaceutical mngt.pdf. Last accessed October 22, 2009.